Warburg Pincus
Ruoxi Chen is based in New York, joined Warburg Pincus in 2011, and focuses on investments in the Healthcare sector. Prior to joining Warburg Pincus, Mr. Chen worked at the Carlyle Group in the U.S. Buyout Fund, and at Citigroup. Mr. Chen is a member of the Board of Directors of Silk Road Medical and Vertice Pharma and has been involved in the firm’s investments in Accriva Diagnostics, ComplexCare, RegionalCare Hospital Partners, Rib-X Pharmaceuticals, Singular Bio, Sotera Health and Tornier/Wright Medical. He received a B.S. magna cum laude in Economics and Computer Science from Duke University and an M.B.A. from Harvard Business School.
Warburg Pincus
21 followers
Warburg Pincus LLC is a leading global growth investor. The firm has more than $73 billion in assets under management. The firm’s active portfolio of more than 235 companies is highly diversified by stage, sector, and geography. Warburg Pincus is an experienced partner to management teams seeking to build durable companies with sustainable value. Founded in 1966, Warburg Pincus has raised 20 private equity and 2 real estate funds, which have invested more than $101 billion in over 1,000 companies in more than 40 countries. The firm is headquartered in New York with offices in Amsterdam, Beijing, Berlin, Hong Kong, Houston, London, Luxembourg, Mumbai, Mauritius, San Francisco, São Paulo, Shanghai, and Singapore.